New Trial Aims to Boost Kids’ Immune Systems to Fight Neuroblastoma
A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families.| Pediatrics Nationwide
A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families.| Pediatrics Nationwide
A subset of patients with high-risk neuroblastoma (NBL) and primary adrenal tumors develop an adrenal insufficiency (AI)-like phenotype during treatment.| Pediatrics Nationwide
